Polycythemia vera risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 10: Line 10:
* Old age ( 65 year old and older)
* Old age ( 65 year old and older)


The risk factors for the development of [[myelofibrosis]] from polycythemia vera include:
The risk factors for the development of [[myelofibrosis]] from polycythemia vera include<ref name="pmid27884974">{{cite journal| author=Vannucchi AM| title=From leeches to personalized medicine: evolving concepts in the management of polycythemia vera. | journal=Haematologica | year= 2017 | volume= 102 | issue= 1 | pages= 18-29 | pmid=27884974 | doi=10.3324/haematol.2015.129155 | pmc=5210229 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27884974  }} </ref>:
*Increased age
*Increased age
*Leukocytosis
*Leukocytosis
Line 17: Line 17:
*Splenomegaly
*Splenomegaly


The risk factors for the development of [[acute myeloid leukemia]] from polycythemia vera include:
The risk factors for the development of [[acute myeloid leukemia]] from polycythemia vera include<ref name="pmid27884974">{{cite journal| author=Vannucchi AM| title=From leeches to personalized medicine: evolving concepts in the management of polycythemia vera. | journal=Haematologica | year= 2017 | volume= 102 | issue= 1 | pages= 18-29 | pmid=27884974 | doi=10.3324/haematol.2015.129155 | pmc=5210229 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27884974  }} </ref>:
*Increased age
*Increased age
*Leukocytosis
*Leukocytosis
*Splenomegaly
*Splenomegaly
*Abnormal karyotype
*Abnormal karyotype


==References==
==References==

Revision as of 01:30, 21 January 2018

Polycythemia vera Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Polycythemia vera from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Polycythemia vera risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polycythemia vera risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polycythemia vera risk factors

CDC on Polycythemia vera risk factors

Polycythemia vera risk factors in the news

Blogs on Polycythemia vera risk factors

Directions to Hospitals Treating Polycythemia vera

Risk calculators and risk factors for Polycythemia vera risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Shyam Patel [3]

Overview

Common risk factors in the development of polycythemia vera are a positive history of thrombotic event and old age ( 65 year old and older).[1]

Common Risk Factors

Common risk factors in the development of polycythemia vera are:[1]

  • A positive history of thrombotic event
  • Old age ( 65 year old and older)

The risk factors for the development of myelofibrosis from polycythemia vera include[2]:

  • Increased age
  • Leukocytosis
  • High variant allele frequency of the JAK2 mutation (high allele burden)
  • Thrombocytosis
  • Splenomegaly

The risk factors for the development of acute myeloid leukemia from polycythemia vera include[2]:

  • Increased age
  • Leukocytosis
  • Splenomegaly
  • Abnormal karyotype

References

  1. 1.0 1.1 Barbui T, Carobbio A, Rumi E, Finazzi G, Gisslinger H, Rodeghiero F; et al. (2014). "In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology". Blood. 124 (19): 3021–3. doi:10.1182/blood-2014-07-591610. PMID 25377561.
  2. 2.0 2.1 Vannucchi AM (2017). "From leeches to personalized medicine: evolving concepts in the management of polycythemia vera". Haematologica. 102 (1): 18–29. doi:10.3324/haematol.2015.129155. PMC 5210229. PMID 27884974.

Template:Hematology


Template:WikiDoc Sources